Literature DB >> 30988153

Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.

Gwendolyn M Pais1,2, Sean N Avedissian1,2, J Nicholas O'Donnell3, Nathaniel J Rhodes1,2, Thomas P Lodise3, Walter C Prozialeck4, Peter C Lamar4, Cameron Cluff1, Anil Gulati5, Julie C Fitzgerald6, Kevin J Downes7,8, Athena F Zuppa6, Marc H Scheetz9,2,4.   

Abstract

Urinary biomarkers are superior to serum creatinine for defining onset and extent of kidney injury. This study classifies the temporal predictive ability of biomarkers for vancomycin-induced kidney injury (VIKI) as defined by histopathologic damage. Male Sprague-Dawley rats (n = 125) were randomized to receive 150 to 400 mg/kg of body weight/day vancomycin via once or twice daily intraperitoneal injection over 1, 3, or 6 days. Urine was collected once during the 24 h prior to euthanasia or twice for rats treated for 6 days. Receiver operating characteristic (ROC) curves were employed to assess the urinary biomarker performances of kidney injury molecule 1 (KIM-1), clusterin, osteopontin (OPN), cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL) to predict histopathologically defined VIKI (using a national standard pathological assessment scheme from hematoxylin and eosin stained kidneys). Urinary KIM-1, clusterin, and OPN outperformed cystatin C and NGAL with regard to sensitivity and specificity. For the earliest injury, urinary KIM-1 (area under the receiver operating characteristic curve [AUC], 0.662; P < 0.001) and clusterin (AUC, 0.706; P < 0.001) were the most sensitive for predicting even low-level histopathologic damage at 24 h compared to NGAL. KIM-1 and clusterin are the earliest and most sensitive predictors of VIKI. As injury progresses, KIM-1, clusterin, and OPN best define the extent of damage.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  KIM-1; PK/PD; PK/TD; biomarker; histopathology; injury; kidney; toxicity; urinary; vancomycin

Mesh:

Substances:

Year:  2019        PMID: 30988153      PMCID: PMC6591602          DOI: 10.1128/AAC.00079-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

1.  Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury.

Authors:  Frank Dieterle; Elias Perentes; André Cordier; Daniel R Roth; Pablo Verdes; Olivier Grenet; Serafino Pantano; Pierre Moulin; Daniel Wahl; Andreas Mahl; Peter End; Frank Staedtler; François Legay; Kevin Carl; David Laurie; Salah-Dine Chibout; Jacky Vonderscher; Gérard Maurer
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.

Authors:  Josef S Ozer; Frank Dieterle; Sean Troth; Elias Perentes; André Cordier; Pablo Verdes; Frank Staedtler; Andreas Mahl; Olivier Grenet; Daniel R Roth; Daniel Wahl; François Legay; Daniel Holder; Zoltan Erdos; Katerina Vlasakova; Hong Jin; Yan Yu; Nagaraja Muniappa; Tom Forest; Holly K Clouse; Spencer Reynolds; Wendy J Bailey; Douglas T Thudium; Michael J Topper; Thomas R Skopek; Joseph F Sina; Warren E Glaab; Jacky Vonderscher; Gérard Maurer; Salah-Dine Chibout; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

Review 3.  Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

Authors:  Sepideh Elyasi; Hossein Khalili; Simin Dashti-Khavidaki; Amirhooshang Mohammadpour
Journal:  Eur J Clin Pharmacol       Date:  2012-03-13       Impact factor: 2.953

4.  Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Authors:  Nathaniel J Rhodes; Walter C Prozialeck; Thomas P Lodise; Natarajan Venkatesan; J Nicholas O'Donnell; Gwendolyn Pais; Cameron Cluff; Peter C Lamar; Michael N Neely; Anil Gulati; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis.

Authors:  Subhankar Chakraborty; Sukhwinder Kaur; Venkata Muddana; Neil Sharma; Uwe A Wittel; Georgios I Papachristou; David Whitcomb; Randall E Brand; Surinder K Batra
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

6.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; Willam A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

7.  Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients.

Authors:  Emi Minejima; Joyce Choi; Paul Beringer; Mimi Lou; Edmund Tse; Annie Wong-Beringer
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

8.  Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury.

Authors:  Walter C Prozialeck; Joshua R Edwards; Peter C Lamar; Jie Liu; Vishal S Vaidya; Joseph V Bonventre
Journal:  Toxicol Appl Pharmacol       Date:  2009-01-31       Impact factor: 4.219

9.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury.

Authors:  Won K Han; Veronique Bailly; Rekha Abichandani; Ravi Thadhani; Joseph V Bonventre
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

10.  Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.

Authors:  Thomas P Lodise; Ben Lomaestro; Jeffrey Graves; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

View more
  14 in total

1.  The Pharmacodynamic-Toxicodynamic Relationship of AUC and C max in Vancomycin-Induced Kidney Injury in an Animal Model.

Authors:  Sean N Avedissian; Gwendolyn Pais; Jiajun Liu; J Nicholas O'Donnell; Thomas P Lodise; Michael Neely; Walter C Prozialeck; Peter C Lamar; Leighton Becher; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve Monitoring.

Authors:  Jack Chang; Jiajun Liu; Keith S Kaye; Marc H Scheetz
Journal:  Clin Infect Dis       Date:  2021-09-07       Impact factor: 9.079

3.  Glomerular Function and Urinary Biomarker Changes between Vancomycin and Vancomycin plus Piperacillin-Tazobactam in a Translational Rat Model.

Authors:  Jack Chang; Gwendolyn M Pais; Kimberly Valdez; Sylwia Marianski; Erin F Barreto; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2022-01-10       Impact factor: 5.938

4.  Vancomycin Pharmacokinetics in a Pregnancy Rat Model.

Authors:  Sean N Avedissian; Gwendolyn M Pais; Michelle Pham; Jiajun Liu; Jack Chang; Khrystyna Hlukhenka; Walter Prozialeck; Brooke Griffin; Anil Gulati; Medha D Joshi; Ying Mu; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2022-04-21       Impact factor: 5.938

Review 5.  Vancomycin-Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.

Authors:  Gwendolyn M Pais; Jiajun Liu; Sanja Zepcan; Sean N Avedissian; Nathaniel J Rhodes; Kevin J Downes; Ganesh S Moorthy; Marc H Scheetz
Journal:  Pharmacotherapy       Date:  2020-05-04       Impact factor: 4.705

Review 6.  Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis.

Authors:  Ioannis Bellos; Vasilios Pergialiotis; Despina N Perrea
Journal:  Int Urol Nephrol       Date:  2021-03-14       Impact factor: 2.370

7.  The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.

Authors:  Moeko Tsutsuura; Hiromu Moriyama; Nana Kojima; Yuki Mizukami; Sho Tashiro; Sumika Osa; Yuki Enoki; Kazuaki Taguchi; Kazutaka Oda; Satoshi Fujii; Yoshiko Takahashi; Yukihiro Hamada; Toshimi Kimura; Yoshio Takesue; Kazuaki Matsumoto
Journal:  BMC Infect Dis       Date:  2021-02-06       Impact factor: 3.090

8.  Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury.

Authors:  Sang-Mi Kim; Hyun-Seung Lee; Min-Ji Kim; Hyung-Doo Park; Soo-Youn Lee
Journal:  J Clin Med       Date:  2021-10-27       Impact factor: 4.241

Review 9.  Vancomycin-Associated Acute Kidney Injury: A Narrative Review from Pathophysiology to Clinical Application.

Authors:  Wei-Chih Kan; Yi-Chih Chen; Vin-Cent Wu; Chih-Chung Shiao
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

Review 10.  Acute Kidney Injury in Septic Patients Treated by Selected Nephrotoxic Antibiotic Agents-Pathophysiology and Biomarkers-A Review.

Authors:  Nadezda Petejova; Arnost Martinek; Josef Zadrazil; Marcela Kanova; Viktor Klementa; Radka Sigutova; Ivana Kacirova; Vladimir Hrabovsky; Zdenek Svagera; David Stejskal
Journal:  Int J Mol Sci       Date:  2020-09-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.